Taste loss in COVID-19-psychophysical evidence supporting a low prevalence

Research output: Contribution to journalLetterContributedpeer-review

Contributors

  • CA Hintschich - , University Hospital Regensburg (Author)
  • S Le Bon - , Geneva University Hospitals, CHU Saint-Pierre Saint-Pierre University Hospital (Author)
  • E Trecca - , University Hospital of Foggia, IRCCS Ospedale Casa Sollievo della Sofferenza - San Giovanni Rotondo (FG) (Author)
  • S Saussez - , University of Mons (Author)
  • T Hummel - , Department of Otorhinolaryngology, Head and Neck Surgery (Author)

Abstract

Much - possibly even too much - has been published about chemosensory dysfunction as a consequence of COVID-19. Studies have reported prevalence of taste loss in up to 89.9%, which is in a similar range as COVID-19 related smell loss. However, most of these publications rely solely on patients' self-reports. Only few studies used validated psychophysical tests to specifically address olfaction and gustation. Especially for gustation, it is evident that subjective reporting does not correlate well with more objective psychophysical findings, often leading to an overestimation of subjectively impaired taste.

Details

Original languageEnglish
Pages (from-to)511-512
Number of pages2
JournalRhinology
Volume62
Issue number4
Publication statusPublished - 1 Aug 2024
Peer-reviewedYes

External IDs

PubMed 38530198
Scopus 85200622879
ORCID /0000-0001-9713-0183/work/165878210

Keywords